drugset / Trial / NCT02210728

Efficacy of Cognitive Behavioral Therapy in Treatment of Adults With Attention Deficit Hyperactivity Disorder

NCT02210728

Unknown 200 enrolled Lily Hechtman
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the project is to evaluate the efficacy of cognitive behavioral therapy (CBT) for adults with attention deficit hyperactivity disorder (ADHD) with and without stimulant medication and compare it to medication alone. Subjects will be randomly assigned to stimulant medication only, CBT only and combined CBT and stimulant medication group. Patients will be evaluated at baseline, following mediation optimization (for medicated groups), following 12 months of treatment, after 3 months of follow up, and after 6 months of follow up. The investigators hypothesize that the combined group will have the best outcome at all evaluation points. ADHD in adults is associated with significant morbidity and impaired academic, occupational, social, and emotional functioning. Developing optimal treatment approaches for this population is key in improving their functioning.

Timeline

Start
2006-04
Primary completion
2018-10
Completion
2018-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dextroamphetamine Small molecule
Comparator Lisdexamfetamine Dimesylate Small molecule
Comparator Methylphenidate Small molecule